Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal …
PA Sarafidis, A Persu, R Agarwal… - Nephrology dialysis …, 2017 - academic.oup.com
In patients with end-stage renal disease (ESRD) treated with haemodialysis or peritoneal
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
[HTML][HTML] Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
K Kalantar-Zadeh, G Block, MH Humphreys… - Kidney international, 2003 - Elsevier
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
Conventional risk factors of cardiovascular disease and mortality in the general population …
Conventional risk factors of cardiovascular disease and mortality in the general population …
[HTML][HTML] A whole-body model to distinguish excess fluid from the hydration of major body tissues
PW Chamney, P Wabel, UM Moissl, MJ Müller… - The American journal of …, 2007 - Elsevier
Abstract Background: Excess fluid (ExF) accumulates in the body in many conditions.
Currently, there is no consensus regarding methods that adequately distinguish ExF from fat …
Currently, there is no consensus regarding methods that adequately distinguish ExF from fat …
[HTML][HTML] Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS
R Saran, JL Bragg-Gresham, NW Levin… - Kidney international, 2006 - Elsevier
Longer treatment time (TT) and slower ultrafiltration rate (UFR) are considered
advantageous for hemodialysis (HD) patients. The study included 22 000 HD patients from …
advantageous for hemodialysis (HD) patients. The study included 22 000 HD patients from …
Dry-weight reduction in hypertensive hemodialysis patients (DRIP) a randomized, controlled trial
Volume excess is thought to be important in the pathogenesis of hypertension among
hemodialysis patients. To determine whether additional volume reduction will result in …
hemodialysis patients. To determine whether additional volume reduction will result in …
Epidemiology of hypertension in CKD
B Horowitz, D Miskulin, P Zager - Advances in chronic kidney disease, 2015 - Elsevier
Both hypertension (HTN) and CKD are serious interrelated global public health problems.
Nearly 30% and 15% of US adults have HTN and CKD, respectively. Because HTN may …
Nearly 30% and 15% of US adults have HTN and CKD, respectively. Because HTN may …
Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload
P Wabel, U Moissl, P Chamney, T Jirka… - Nephrology Dialysis …, 2008 - academic.oup.com
Background. Hypertension and fluid overload (FO) are well-recognized problems in the
chronic kidney disease (CKD) population. While the prevalence of hypertension is well …
chronic kidney disease (CKD) population. While the prevalence of hypertension is well …
Assessment and management of hypertension in patients on dialysis
Hypertension is common, difficult to diagnose, and poorly controlled among patients with
ESRD. However, controversy surrounds the diagnosis and treatment of hypertension. Here …
ESRD. However, controversy surrounds the diagnosis and treatment of hypertension. Here …
EBPG guideline on dialysis strategies
J Tattersall, A Martin-Malo, L Pedrini… - Nephrology Dialysis …, 2007 - academic.oup.com
Outline Guideline 1. Time and frequency 1.1 Minimum length and frequency of sessions. 1.2
Cardiovacular instability. 1.3 Hypertension. 1.4 Hyperphosphataemia. 1.5 Malnutrition …
Cardiovacular instability. 1.3 Hypertension. 1.4 Hyperphosphataemia. 1.5 Malnutrition …
[HTML][HTML] Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis
Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
Background Left ventricular hypertrophy (LVH) is an independent risk factor for mortality in …
Background Left ventricular hypertrophy (LVH) is an independent risk factor for mortality in …